 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 1 | 1/1 | 返回列表 |
| 查看: 687 | 回復(fù): 0 | |||
letterman新蟲 (小有名氣)
|
[交流]
Current drug target for Prostate Cancer
|
|
[Content] In this series, each posting will include the current or emerging drug targets for one type of cancer. [Intended audience] Students and researchers who are interested in anticancer drug discovery. Topic 1: Current drug targets and emerging drug targets for prostate cancer Prostate cancer is critically depending on the signaling of androgen receptor (AR). Current major drug target for advanced prostate cancer is the AR. There are three domains in the AR: i) The N-terminal domain (NTD); ii) DNA-binding domain (DBD); and iii) Ligand-binding domain (LBD). When the hormone (DHT) binds with AR that the LBD, the AR signaling is activated. Thus, the current strategy to inhibit the AR signaling is to develop compounds to bind with AR at the LBD (to prevent the binding of DHT with AR). Such compounds are referred to as anti-androgen and a number of such compounds have been developed into drugs, including bicalutamide and enzalutamide. However, during the treatment of anti-androgen, despite of initial response, the patients almost always become resistance to the treatment and the AR signaling is reactivated (despite of the anti-androgen treatment). While there are many possible mechanisms have been proposed, there are two key mechanisms: First, the emergence of AR splice variants that do not have the LBD confer resistance to the LBD-targeting antiandrogens. It is important to note that all of the current clinically used antiandrogens are designed to target the AR LBD; Second, the mutation in the AR LBD could confer resistance to antiandrogens. Worse yet, some mutations at the LBD could lead to the AR mutants that are activated by antiandrogensuch as enzalutamide. How to develop potent and selective inhibitors of the AR splice variants is a burning issue in the field. One approach is to target the AR NTD, but this is very challenging. The major reason is that the AR NTD is intrinsically disorder. No crystal structure of the AR NTD is available. Nevertheless, the 3rd generation of antiandrogens could be the compounds that target the AR NTD. |
回復(fù)此樓» 猜你喜歡
是不是現(xiàn)在考博都是推薦制？或者是已經(jīng)內(nèi)定了？還有通過考試招博士的學(xué)校嗎？
已經(jīng)有39人回復(fù)
-
農(nóng)產(chǎn)品中農(nóng)藥監(jiān)測的免疫傳感器的疑問
已經(jīng)有0人回復(fù)
-
藥理學(xué)論文潤色/翻譯怎么收費(fèi)?
已經(jīng)有67人回復(fù)
-
納米傳感器監(jiān)測農(nóng)藥殘留的疑惑
已經(jīng)有0人回復(fù)
-
求助《生物利用度和生物等效性研究指導(dǎo)原則》（試 行），2002
已經(jīng)有0人回復(fù)
-
誰有人衛(wèi)版 《毒理學(xué)基礎(chǔ)》第七版書籍
已經(jīng)有0人回復(fù)
-
文獻(xiàn)求助
已經(jīng)有0人回復(fù)
-
26有沒有老師想收做定量藥理的學(xué)生啊
已經(jīng)有3人回復(fù)
-
26考博申請 學(xué)or專
已經(jīng)有15人回復(fù)
相關(guān)版塊跳轉(zhuǎn)
我要訂閱樓主 letterman 的主題更新
| 1 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 材料085601一志愿哈工大317 +3 | 壓迫感行 2026-03-04 | 3/150 |
|
|---|---|---|---|---|
|
|
[考研] 復(fù)試調(diào)劑 +3 | 呼呼？~+123456 2026-03-05 | 5/250 |
|
|
[考研] 322分 085600求調(diào)劑，有互聯(lián)網(wǎng)+國金及主持省級大創(chuàng)經(jīng)歷 +6 | 熊境喆 2026-03-04 | 6/300 |
|
|
|
[考研] 295求調(diào)劑 +4 | 小賽不吃香菜 2026-03-04 | 4/200 |
|
|
|
[考研] 0857求調(diào)劑 +4 | CDDD1013 2026-03-04 | 4/200 |
|
|
|
[考研] 312求調(diào)劑 +8 | 醋精華了一下發(fā)?/a> 2026-03-03 | 10/500 |
|
|
|
[考研] 材料化工調(diào)劑 +15 | 今夏不夏 2026-03-01 | 18/900 |
|
|
|
[考研] 求調(diào)劑 +3 | 泡了個椒 2026-03-04 | 3/150 |
|
|
|
[考研]
085600 英一數(shù)二272求調(diào)劑
 5+6
|
vida_a 2026-03-01 | 47/2350 |
|
|
|
[考研] 材料工程269求調(diào)劑 +7 | 白刺玫 2026-03-02 | 7/350 |
|
|
|
[考研] 復(fù)試調(diào)劑 +4 | 杰尼龜aaa 2026-03-03 | 4/200 |
|
|
|
[考研] 理學(xué)，工學(xué)，農(nóng)學(xué)調(diào)劑，少走彎路，這里歡迎您！ +8 | likeihood 2026-03-02 | 11/550 |
|
|
|
[考研]
 計算機(jī)學(xué)碩 分?jǐn)?shù)285求調(diào)劑
+4
|
glwshine 2026-03-02 | 5/250 |
|
|
|
[論文投稿]
通訊作者寫誰，問題是你意想不到的問題
15+3
|
阿爾法啊 2026-03-01 | 3/150 |
|
|
|
[考研] 271求調(diào)劑 +4 | Ricardo1113 2026-03-02 | 4/200 |
|
|
|
[考研] 338求調(diào)劑 +5 | 18162027187 2026-03-02 | 6/300 |
|
|
|
[考研] 化學(xué)，材料，環(huán)境類求調(diào)劑 +7 | 考研版棒棒 2026-03-02 | 7/350 |
|
|
|
[考研] 材料調(diào)劑 +3 | 恒順自然 2026-03-02 | 3/150 |
|
|
|
[考研] 化工專碩342，一志愿大連理工大學(xué)，求調(diào)劑 +6 | kyf化工 2026-02-28 | 7/350 |
|
|
|
[考研] 328求調(diào)劑 +3 | aaadim 2026-03-01 | 5/250 |
|